Recalls & Warnings June 21, 2005 FTC Settles Claims with Marketers of FiberThin and Propolene On June 20, 2005, the Federal Trade Commission (FTC) announced that the marketers of the dietary supplements FiberThin and Propolene have settled FTC charges that their misleading weight-loss claims violated federal laws
This question is increasingly relevant as GLP-1 receptor agonists like semaglutide and liraglutide become more widely prescribed for weight management in the UK
Oral: Rare for peptides due to gastrointestinal degradation
DOI: Published online: July 24, 2025 1 Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Correspondence to Seok-Woo Hong, PhD Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea Email: [email protected] Won-Young Lee, MD Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea Email: [email protected] *Jinmi Lee and Eun-Jung Rhee contributed equally to this work as co-first authors
Maksimov, Aleksander M